Toxic Epidermal Necrolyis after Vancomycin Use: A Case Report and Discussion of Management

被引：2
作者：
Changela, Avani [1 ]
Javaiya, Hemangkumar [1 ]
Rickenback, Kiersten [2 ]
Elnawawi, Ashraf [3 ]
Changela, Kinesh [1 ]
机构：
[1] Brooklyn Hosp Ctr, Dept Internal Med, Brooklyn, NY 11201 USA
[2] Brooklyn Hosp Ctr, Dept Dermatol, Brooklyn, NY 11201 USA
[3] Brooklyn Hosp Ctr, Dept Pathol, Brooklyn, NY 11201 USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2013年 / 20卷 / 02期
关键词：
vancomycin; toxic epidermal necrolysis; dermoepidermal junction; apoptosis; LYELLS-SYNDROME; PATIENT; CARE;
D O I：
10.1097/MJT.0b013e3181f94c27
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Vancomycin is a commonly used antibiotic for severe Gram-positive bacterial infections, especially for methicillin-resistant Staphylococcus Aureus and coagulase-negative staphylococci infections. Nevertheless, only few cases of toxic epidermal necrolysis have been reported since the introduction of Vancomycin into clinical practice. We report a case of a 35-year-old man who presented with multiple facial abscesses and methicillin-resistant Staphylococcus Aureus bactermia and who was started on Vancomycin and later developed toxic epidermal necrolysis.
引用
收藏
页码：223 / 225
页数：3
相关论文
共 16 条
  • [1] Arévalo JM, 2000, J TRAUMA, V48, P473
  • [2] Antitumour necrosis factor-α antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis
    Fischer, M
    Fiedler, E
    Marsch, WC
    Wohlrab, J
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (04) : 707 - 708
  • [3] IMPROVED BURN CENTER SURVIVAL OF PATIENTS WITH TOXIC EPIDERMAL NECROLYSIS MANAGED WITHOUT CORTICOSTEROIDS
    HALEBIAN, PH
    CORDER, VJ
    MADDEN, MR
    FINKLESTEIN, JL
    SHIRES, GT
    [J]. ANNALS OF SURGERY, 1986, 204 (05) : 503 - 512
  • [4] EFFICACY OF CYCLOPHOSPHAMIDE IN TOXIC EPIDERMAL NECROLYSIS - CLINICAL AND PATHOPHYSIOLOGIC ASPECTS
    HENG, MCY
    ALLEN, SG
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (05) : 778 - 786
  • [5] TOXIC EPIDERMAL NECROLYSIS TREATED WITH CYCLOSPORINE
    HEWITT, J
    ORMEROD, AD
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1992, 17 (04) : 264 - 265
  • [6] PLASMAPHERESIS IN SEVERE DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS
    KAMANABROO, D
    SCHMITZLANDGRAF, W
    CZARNETZKI, BM
    [J]. ARCHIVES OF DERMATOLOGY, 1985, 121 (12) : 1548 - 1549
  • [7] KELEMEN JJ, 1995, J AM COLL SURGEONS, V180, P273
  • [8] Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003
    Klevens, RM
    Edwards, JR
    Tenover, FC
    McDonald, LC
    Horan, T
    Gaynes, R
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (03) : 389 - 391
  • [9] Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative β-lactam cross-reactivity:: Case report and scrutiny of antibiotic imputability
    Paquet, P
    Jacob, E
    Damas, P
    Piérard, GE
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (11) : 2580 - 2583
  • [10] Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins
    Paquet, P
    Jacob, E
    Damas, P
    Piérard, GE
    [J]. BURNS, 2001, 27 (06) : 652 - 655
12